HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib

HER2 mutations have emerged as oncogenic driver gene mutations in non-small cell lung cancer (NSCLC), which have not been described in detail like other driver gene mutations. Here, 295 patients with advanced lung adenocarcinoma were retrospectively screened for HER2 mutations using next-generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinyong, Lv, Jialin, Wu, Yuhua, Qin, Na, Ma, Li, Li, Xi, Nong, Jingying, Zhang, Hui, Zhang, Quan, Yang, Xinjie, Shi, Huibo, Wang, Jinghui, Zhang, Shucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411254/
https://www.ncbi.nlm.nih.gov/pubmed/32850330
http://dx.doi.org/10.3389/fonc.2020.01162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411254/
https://www.ncbi.nlm.nih.gov/pubmed/32850330
http://dx.doi.org/10.3389/fonc.2020.01162

Ejemplares similares